COMPUGEN LTD — Investor Relations & Filings
Filings indexed
556
across all filing types
Latest filing
2026-03-26
Regulatory Filings
Country
US
United States of America
Listing
US
CGEN
Compugen Ltd. is a clinical-stage therapeutic discovery and development company focused on cancer immunotherapy. The company utilizes a proprietary, predictive computational platform powered by artificial intelligence and machine learning to systematically identify novel drug targets and biological pathways. This technology enables the discovery and development of first-in-class and best-in-class therapeutics. Compugen's pipeline consists of immuno-oncology programs, including antibody-based product candidates, which are advanced through preclinical and clinical development stages.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 144 - COMPUGEN LTD (0001119774) (Subject) | 2026-03-26 | English | |
| 3 - COMPUGEN LTD (0001119774) (Issuer) | 2026-03-18 | English | |
| 3 - COMPUGEN LTD (0001119774) (Issuer) | 2026-03-18 | English | |
| 3 - COMPUGEN LTD (0001119774) (Issuer) | 2026-03-18 | English | |
| 3 - COMPUGEN LTD (0001119774) (Issuer) | 2026-03-18 | English | |
| 3 - COMPUGEN LTD (0001119774) (Issuer) | 2026-03-18 | English |
| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
8 filings
| |||||
| 33049795 | 144 - COMPUGEN LTD (0001119774) (Subject) | 2026-03-26 | English | ||
| 32972774 | 3 - COMPUGEN LTD (0001119774) (Issuer) | 2026-03-18 | English | ||
| 32973927 | 3 - COMPUGEN LTD (0001119774) (Issuer) | 2026-03-18 | English | ||
| 32973751 | 3 - COMPUGEN LTD (0001119774) (Issuer) | 2026-03-18 | English | ||
| 32972842 | 3 - COMPUGEN LTD (0001119774) (Issuer) | 2026-03-18 | English | ||
| 32972825 | 3 - COMPUGEN LTD (0001119774) (Issuer) | 2026-03-18 | English | ||
| 32887767 | 20-F - COMPUGEN LTD (0001119774) (Filer) | 2026-03-02 | English | ||
| 27960311 | 6-K Filing | 2026-02-12 | English | ||
|
2025
7 filings
| |||||
| 11348906 | 6-K | 2025-12-17 | English | ||
| 11348907 | 6-K | 2025-11-10 | English | ||
| 11349023 | 6-K | 2025-10-14 | English | ||
| 11348908 | 6-K | 2025-09-17 | English | ||
| 11348909 | 6-K | 2025-08-06 | English | ||
| 11348918 | 6-K | 2025-08-06 | English | ||
| 11348922 | 6-K | 2025-07-21 | English | ||
Market data
Market data not available
Last price
Market cap
volume
Day range
today
52-week range
trailing
Price history
Peer group · Research and experimental development on natural sciences and engineering
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
ChemPartner PharmaTech Co., Ltd.
Global CRO and CDMO providing integrated drug discovery and…
|
300149 | CN | Professional, scientific and te… |
|
CHIMERIC THERAPEUTICS LIMITED
Clinical-stage cell therapy company developing CAR T and NK…
|
CHM | AU | Professional, scientific and te… |
|
China National Electric Apparatus Research Institute Co., Ltd.
R&D institution for electrical and electronics testing, equ…
|
688128 | CN | Professional, scientific and te… |
|
Chiome Bioscience Inc.
Clinical-stage biotech company developing antibody-based th…
|
4583 | JP | Professional, scientific and te… |
|
CHITOGENX INC
Clinical stage regenerative medicine company focused on nov…
|
CHGX | CA | Professional, scientific and te… |
|
Chordate Medical Holding AB
Develops a patented, drug-free neuromodulation treatment fo…
|
CMH | SE | Professional, scientific and te… |
|
Chordia Therapeutics,Inc
Clinical-stage biotech developing novel cancer therapies ta…
|
190A | JP | Professional, scientific and te… |
|
Cibus, Inc.
Develops and licenses plant traits using non-GMO precision …
|
CBUS | US | Professional, scientific and te… |
|
Circio Holding ASA
Clinical-stage company developing circular RNA medicines an…
|
CRNA | NO | Professional, scientific and te… |
|
CIZZLE BIOTECHNOLOGY HOLDINGS PLC
A cancer diagnostics developer creating a blood test for ea…
|
CIZ | GB | Professional, scientific and te… |
COMPUGEN LTD via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/33979/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=33979 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=33979 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=33979 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 33979}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for COMPUGEN LTD (id: 33979)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.
We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.